BlossomHill Therapeutics, Inc. share price logo

BlossomHill Therapeutics, Inc.

NASDAQ: BLSM

Small Cap

$12.31

-0.11

(-0.85%)

Live

as on

BlossomHill Therapeutics, Inc. Stock Performance

as on November 4, 2026 at 4:58 am IST

  • Day's Low

    Day's High

    $12.20
    $12.77
    downward going graph

    0.89%

    Downside

    3.74%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

BlossomHill Therapeutics, Inc. share price movements today

Previous Close
$12.42
Open
$12.41
Volume
248.7K
Market Cap
$437.0M
Day's Low - High
$12.20 - $12.77

BlossomHill Therapeutics, Inc. Historical Returns

1 Month Return
-36.92 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

BlossomHill Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check BlossomHill Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$437.0M

EPS (TTM)

-9.47

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.45

Industry PE ratio

-7.24

PEG Ratio

-0.01

EBITDA

-46.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

127.76%

BlossomHill Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BlossomHill Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$437.0MNA-1.450.00%0.00%
Neutral$88.5B-36.16%-27.78-12.57%0.00%
StrongBuy$141.7B192.56%32.2786.04%0.00%
Buy$95.5B47.41%19.7685.77%0.40%

Analyst Recommendation on BlossomHill Therapeutics, Inc. Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for BlossomHill Therapeutics, Inc.. Average target price of $35.4

BlossomHill Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on BlossomHill Therapeutics, Inc..

Current Price

$12.31

Analyzed by

5 Analysts

High

$40

0

Low

$30

BlossomHill Therapeutics, Inc. target price $0, a slight upside of 0% compared to current price of $12.31. According to 5 analysts rating.

Indian Investors' Interest in BlossomHill Therapeutics, Inc. Stock

Search interest for BlossomHill Therapeutics, Inc. Stock has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-61% versus previous 30 day period

BlossomHill Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2026
Jun 2026
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-22
-24
EBITDA
-21
-24
Interest Expense
-
-
Depreciation
0
-
Income Before Tax
-21
-23
Income Tax Expense
-
-
Net Income
-21
-23
Net Profit Margin
0.00%
0.00%

BlossomHill Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2024
Dec 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-36
-64
EBITDA
-36
-63
Interest Expense
-
-
Depreciation
0
0
Income Before Tax
-30
-60
Income Tax Expense
-
-
Net Income
-30
-60
Net Profit Margin
0.00%
0.00%

BlossomHill Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2026
Jun 2026
Net Income
-21
-23
Operating Cash Flow
-20
-23
Investing Cash Flow
0
-
Financing Cash Flow
0
2
Change in Cash
-20
-20

BlossomHill Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2024
Dec 2025
Net Income
-30
-60
Operating Cash Flow
-31
-46
Investing Cash Flow
0
-1
Financing Cash Flow
17
84
Change in Cash
-13
36

Global Institutional Holdings in BlossomHill Therapeutics, Inc.

Check out the Institutions with significant holdings in BlossomHill Therapeutics, Inc..

Funds
Holdings
Yishan Li
12.50%
Jean Cui Jingrong
12.50%
Bihua Chen
11.37%
Orbimed Advisors Llc
8.54%
Carl Gordon
8.54%

BlossomHill Therapeutics, Inc. News & Key Events

    Insights on BlossomHill Therapeutics, Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, BLSM stock has moved down by -21.2%

    About BlossomHill Therapeutics, Inc.

    Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
    OrganisationBlossomHill Therapeutics, Inc.
    Headquarters10255 Science Center Drive, Suite 200, San Diego, CA, 92121, US
    IndustryBiotechnology
    CEOJing Rong Jean Cui

    Key Management of BlossomHill Therapeutics, Inc.

    Name

    Title

    Dr. Zachary F. Zimmerman M.D., Ph.D.

    Senior Vice President of Clinical Development

    Dr. Eugene Y. Rui Ph.D.

    Senior Vice President of Chemistry

    Dr. Vincent Liptak J.D., M.B.A., Ph.D.

    General Counsel & Executive VP

    Dr. Jingrong Jean Cui Ph.D.

    Scientific Founder, President, CEO & Director

    Mr. Jason A. Keyes M.B.A.

    CFO & Executive VP

    Dr. Geoff Oxnard M.D.

    Chief Medical Officer & Executive VP

    Dr. Z. Jesse Shao Ph.D., R.Ph.

    Senior Vice President of CMC

    Dr. Ashley Preston Ph.D.

    Senior VP and Head of Regulatory Affairs & Quality Assurance

    Dr. Antonio Garrido-Montalban Ph.D.

    Senior Vice President of Drug Substance

    Dr. Yishan Li M.B.A., Ph.D.

    Co-Founder & Executive Chairman

    FAQs

    What is BlossomHill Therapeutics, Inc. share price today?

    BlossomHill Therapeutics, Inc. share price today is $12.31 as on . BlossomHill Therapeutics, Inc. share today touched a day high of $12.77 and a low of $12.20.

    What is the 52 week high and 52 week low for BlossomHill Therapeutics, Inc. share?

    BlossomHill Therapeutics, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . BlossomHill Therapeutics, Inc. stock price today i.e. is trending at $12.31,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

    What is BlossomHill Therapeutics, Inc.'s market capitalisation today?

    BlossomHill Therapeutics, Inc. market capitalisation is $0.00T as on .

    How to invest in BlossomHill Therapeutics, Inc. Stock (BLSM) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for BlossomHill Therapeutics, Inc. on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy BlossomHill Therapeutics, Inc. Stock (BLSM) from India?

    Indian investors can start investing in BlossomHill Therapeutics, Inc. (BLSM) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹947.40 in BlossomHill Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on BlossomHill Therapeutics, Inc. share’s latest price of $12.31 as on November 3, 2026 at 11:28 pm IST, you will get 0.8123 shares of BlossomHill Therapeutics, Inc.. Learn more about fractional shares .